Beardsley Robert A 4
4 · Galera Therapeutics, Inc. · Filed Dec 20, 2021
Insider Transaction Report
Form 4
Beardsley Robert A
Chief Operating Officer
Transactions
- Exercise/Conversion
Stock Option
2021-12-17−20,000→ 95,651 totalExercise: $1.07Exp: 2022-11-25→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2021-12-17$1.07/sh+20,000$21,400→ 88,191 total
Footnotes (1)
- [F1]The option has fully vested and is currently exercisable.